PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Supplementation significantly decreased low-density lipoprotein cholesterol (LDL) concentration [PMID:33624557].
Dill seeds significantly reduced the duration of the first, second, and third stages of labor [PMID:33130423].
Evidence suggests hypolipidemic and hypoglycemic effects and a reduction in the incidence of diabetic complications [PMID:27829842].
Study evaluated effects on TSH, FT3, FT4, anti-TPO, anti-Tg, and CRP in patients with benign thyroid nodules [PMID:40329862].
No scientifically valid clinical trials support its use as a galactogogue; one small study found no effect for d-carvone [PMID:30000937].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30000937 (2006) — Anethum graveolens L. (Dill) Effect on Human Lipid Profile: An Updated Systematic Review. · Current problems in cardiology
- 2.PMID: 33130423 (2020) — Effect of dill (Anethum Graveolens Linn) seed on the duration of labor: A systematic review. · Complementary therapies in clinical practice
- 3.PMID: 33624557 (2022) — The effects of Anethum graveolens (dill) supplementation on lipid profile and glycemic control: a systematic review and meta-analysis of randomized controlled trials. · Critical reviews in food science and nutrition
- 4.PMID: 36534115 (2023) — Biosynthesis of dillapiole/apiole in dill (Anethum graveolens): characterization of regioselective phenylpropene O-methyltransferase. · The Plant journal : for cell and molecular biology
- 5.PMID: 27829842